Trial intelligence / Profile preview

Vitamin D supplementation in polymorphic light eruption

2012-000300-15Phase 3Terminated

Sponsor
Medical University of Graz
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in polymorphic light eruption (PMLE) and photodermatoses comparing Colecalciferol with Placebo (2 arms). Primary endpoint: PLE test score of experimental photoprovocation. Started Mar 2012; status: terminated.

02

Drugs

cholecalciferol
03

Conditions

polymorphic light eruption (PMLE)photodermatoses

Beyond the preview

Go deeper on 2012-000300-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000300-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call